Stanford India Biodesign programme started in the year 2007 till 2014. School of International Biodesign (SIB) is built on the success of Stanford India Biodesign Programme. School of International Biodesign (SiB) is an innovation program implemented by the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India at All India Institute of Medical Sciences (AIIMS), New Delhi and Indian Institute of Technology Delhi (IITD) in collaboration with QUT Australia and Hiroshima University, Japan. Since the inception of the program, DBT has engaged Biotechnology Consortium of India Limited (BCIL) to manage the techno-legal activities of this Programme. The current duration of this Programme is upto December 2020.
The mandate of this Programme is to train next generation of medical technology innovators in India. The focus is on invention/innovation and early stage development of affordable, accessible and available medical technologies for our population.
During the last 11 years this interdisciplinary Programme has achieved the following; More than 100 medical technology innovators (Doctors, engineers, designers, entrepreneurs) have been trained in the Biodesign process. This includes idea generation through clinical immersion, need finding, need filtration at AIIMS and prototype development at IIT, with IP generation with the help of BCIL towards developing innovative technologies for the country.
More than 50 prototypes have been developed so far which have been further refined validated internationally and tested (both preclinical and clinical trials).
This has led to the development of over 30 medical devices which has been possible by the efforts of young innovators ie 60 Fellows and over 52 Interns who have been meticulously trained in the Biodesign innovation process by the faculty of AIIMS and IIT-D with the international partners. These devices are built on more than 50 patents (National, International and National phase filing). Fifteen technologies have been transferred and twelve medical technology start-ups have been setup by the Fellows trained under this Programme in sync with the ‘Start-Up’ India Programme.
School of International Biodesign (SiB): Is a agship program of the Department of Biotechnology, Ministry of Science and Technology, Govt. of India based at the All India Institute of Medical Sciences (AIIMS), New Delhi and administered in collaboration between AIIMS New Delhi, Indian Institute of Technology (IIT) Delhi and other international Universities.
Fellowship: SiB invites applications for its prestigious, multi-disciplinary ‘iFellowship’ program in medical device innovation. Twice a year SiB accepts teams of fellows consisting of graduates and post graduates from the streams of Medicine, Engineering, Product Design, MBA, Public Health and other related disciplines. The Fellows spend time at AIIMS observing identifying and selecting unmet clinical needs, followed by develop- ment of aordable yet disruptive innovative solutions. Subsequently the fellows work together to bring the solution to the real world as a commercial product. SiB is looking for candidates with an entrepreneurial inclina- tion and a commitment to bring their innovations to patients as soon as possible.
Duration: One year, full time (Jan – Dec 2020)
Eligibility: Candidates with graduate or postgraduate degrees (in Medicine, Engineering, Design, and Busi- ness) are encouraged to apply. Preference would be given to candidates who have demonstrated a track record of innovation, passion for entrepreneurship and are willing to work in a team to create social impact through innovative product realization and commercialization.
Shortlisted candidates will be called for interview at AIIMS, New Delhi.
Benefits: iFellowship pays stipend, travel costs and health coverage. iFellows shall be mentored by faculty members who are from AIIMS Delhi, IIT Delhi, MedTech Industry, start-ups, academia, and hospitals. The program also oers post-fellowship support to promising innovators.
Stipend:Rs. 60,000/- per month (Consolidated)
Last date of application: 11th October 2019